Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus morphine PCIA for prevention of postoperative nausea and vomiting after gynecological laparoscopy
ChiCTR1800017172Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Peking University First Hospital. Primary endpoints: Incidence of postoperative nausea and vomiting and PONV intensity scale. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR1800017172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017172.